139 related articles for article (PubMed ID: 34854369)
1. Jatamansinol from
Anupama KP; Shilpa O; Antony A; Gurushankara HP
J Biomol Struct Dyn; 2023 Jan; 41(1):200-220. PubMed ID: 34854369
[TBL] [Abstract][Full Text] [Related]
2. Jatamansinol from Nardostachys jatamansi Ameliorates Tau-Induced Neurotoxicity in Drosophila Alzheimer's Disease Model.
Anupama KP; Antony A; Shilpa O; Raghu SV; Gurushankara HP
Mol Neurobiol; 2022 Oct; 59(10):6091-6106. PubMed ID: 35864434
[TBL] [Abstract][Full Text] [Related]
3. Jatamansinol from Nardostachys jatamansi (D.Don) DC. Protects Aβ
Anupama KP; Shilpa O; Antony A; Raghu SV; Gurushankara HP
Neurotoxicology; 2022 May; 90():62-78. PubMed ID: 35247505
[TBL] [Abstract][Full Text] [Related]
4. Secondary metabolite profiling, cytotoxicity, anti-inflammatory potential and in vitro inhibitory activities of Nardostachys jatamansi on key enzymes linked to hyperglycemia, hypertension and cognitive disorders.
Bose B; Tripathy D; Chatterjee A; Tandon P; Kumaria S
Phytomedicine; 2019 Mar; 55():58-69. PubMed ID: 30668444
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
6. Nardostachys jatamansi Ethanol Extract Ameliorates Aβ42 Cytotoxicity.
Liu QF; Jeon Y; Sung YW; Lee JH; Jeong H; Kim YM; Yun HS; Chin YW; Jeon S; Cho KS; Koo BS
Biol Pharm Bull; 2018 Apr; 41(4):470-477. PubMed ID: 29398668
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
8. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.
Jabir NR; Shakil S; Tabrez S; Khan MS; Rehman MT; Ahmed BA
J Biomol Struct Dyn; 2021 Sep; 39(14):5083-5092. PubMed ID: 32588759
[TBL] [Abstract][Full Text] [Related]
9. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
10. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
[TBL] [Abstract][Full Text] [Related]
11. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
Mazumder MK; Choudhury S
Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
[TBL] [Abstract][Full Text] [Related]
12. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
14. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
Ambure P; Bhat J; Puzyn T; Roy K
J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
[TBL] [Abstract][Full Text] [Related]
15. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
16. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Gurjar AS; Darekar MN; Yeong KY; Ooi L
Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
[TBL] [Abstract][Full Text] [Related]
17. A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi.
Jalali S; Zarrinhaghighi A; Sadraei S; Ghasemi Y; Sakhteman A; Faridi P
Curr Drug Metab; 2018; 19(5):469-476. PubMed ID: 29512454
[TBL] [Abstract][Full Text] [Related]
18. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Kumar S; Chowdhury S; Kumar S
BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Screening of Traditional Medicinal Plants for Neuroprotective Activity against Aβ42 Cytotoxicity by Using Drosophila Models of Alzheimer's Disease.
Liu QF; Lee JH; Kim YM; Lee S; Hong YK; Hwang S; Oh Y; Lee K; Yun HS; Lee IS; Jeon S; Chin YW; Koo BS; Cho KS
Biol Pharm Bull; 2015; 38(12):1891-901. PubMed ID: 26458335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
